nach oben

European Journal of Pediatrics

Erschienen in:

01.08.2008 | Original Paper

Proposed management of childhood tuberculosis in low-incidence countries

verfasst von: Klaus Magdorf, Anne K. Detjen

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

The incidence of childhood tuberculosis continues to decline in central Europe, but due to migration from high incidence countries paediatricians will still be confronted with it. The management of childhood tuberculosis in low-incidence, high-income countries differs from most high-incidence countries. The primary measures for preventing the transmission of tuberculosis to children are the detection of adult source cases, detection of latent TB infection (LTBI) in children by history, tuberculin skin testing and, if necessary and recommended, interferon-γ release assays. Children with LTBI should receive preventive therapy. The inclusion of tuberculosis in the differential diagnosis of unclear pulmonary and extrapulmonary disease remains important, and tuberculosis has to be managed according to international standards.

Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O (2004) Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 10:388–398PubMedCrossRef

Algood HM, Lin PL, Flynn JL (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41(Suppl 3):S189–S193PubMedCrossRef

Alzeer AH, FitzGerald JM (1993) Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tubercle Lung Dis 74:6–11CrossRef

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Disease Society of America (2003) Treatment of tuberculosis. Am J Resp Crit Care Med 167:63–662

American Thoracic Society, Centers for Disease Control and Prevention (2000) Targeted tuberculin testing, and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161:221–247

Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 13:175–182PubMedCrossRef

Bartmann K, Massmann W (1961) Die Blutspiegel des INH bei Erwachsenen und Kindern. Beitr Klin Tuberk 124:310–319CrossRef

Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, Villiger PM, Zellweger JP (2007) Screening for tuberculosis infection before initiation of anti-TNF-a therapy. Swiss Med Wkly 137:621–622

Bellamy R (2005) Genetic susceptibility to tuberculosis. Clin Chest Med 26:233–246PubMedCrossRef

10.

Brodie D, Schluger NW (2005) The diagnosis of tuberculosis. Clin Chest Med 26:247–271PubMedCrossRef

11.

Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC (2002) European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 19:765–775PubMedCrossRef

12.

Canadian Tuberculosis Committee (2007) Interferon gamma release assays for latent tuberculosis infection. Canada Communicable Disease Report 2007, vol 33. Public Health Agency of Canada

13.

Casanova J-L, Abel L (2004) The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4:55–66PubMedCrossRef

14.

Centers for Disease Control and Prevention (CDC) (2005) Human tuberculosis caused by mycobacterium bovis - New York City, 2001–2004. MMWR 54:605–608

15.

Centers for Disease Control and Prevention (1992) Management of persons exposed to multidrug-resistant tuberculosis. MMWR 41:61–71

16.

Chintu C (2007) Tuberculosis and human immunodeficiency virus co-infection in children: management challenges. Paediatr Respir Rev 8:142–147PubMedCrossRef

17.

Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV (1995) The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96:29–35PubMed

18.

Comstock GW, Caras GJ, Koplan JP (1999) How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 3:847–850PubMed

19.

Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (2001) Richtlinien zur medikamentösen Behandlung der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 55:494–511CrossRef

20.

Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, Magdorf K (2007) Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45:322–328PubMedCrossRef

21.

Diel R, Nienhaus A, Lange C, Schaberg T (2006) Cost-optimization of screening for latent tuberculosis in close contacts. Eur Respir J 28:35–44PubMedCrossRef

22.

Diel R, Forssbohm M, Loytved G, Haas W, Hauer B, Maffei D, Magdorf K, Nienhaus A, Rieder HL, Schaberg T, Zellweger JP, Loddenkemper R (2007) Recommendations for background studies in tuberculosis. Pneumologie 61:440–455PubMedCrossRef

23.

Doherty TM, Demissie A, Menzies D, Andersen P, Rook G, Zumla A, VACSEL Study Group (2005) Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J Immunol Meth 298:129–141CrossRef

24.

Donald PR, Schaaf HS (2007) Old and new drugs for the treatment of tuberculosis in children. Paediatr Respir Rev 8:134–141PubMedCrossRef

25.

Dooley KE, Sterling TR (2005) Treatment of latent tuberculosis infection: challenges and prospects. Clin Chest Med 26:313–326PubMedCrossRef

26.

Drobniewski F, Cobelens F, Zellweger JP; on behalf of the KNCV/Euro TB Workshop (2007) Use of gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/Euro TB, Vilnius Sept 2006. http://www.eurosurveillance.org/ew/2007/070726.asp. Accessed 10 April 2008

27.

Ena J, Valls V (2005) Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 40:670–676PubMedCrossRef

28.

Falzon D, Ait-Belghiti F (2007) What is tuberculosis surveillance in the European Union telling us? Clin Infect Dis 44:1268–1270CrossRef

29.

Feja K, Saiman L (2005) Tuberculosis in children. Clin Chest Med 26:295–312PubMedCrossRef

30.

Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R, Dainotto D, Anzidei G, Nisii C, Ippolito G, Poccia F, Girardi E (2007) Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 8:5PubMedCrossRef

31.

Haimi-Cohen Y (2001) Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis 33:1786–1788PubMedCrossRef

32.

Haute Autorité de Santé (2006) Test de détéction de la production d’interferon-g pour le diagnosis des infection tuberculeuses. http://www.has-sante.fr. Accessed 10 April 2008

33.

Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG, van Dissel JT (2004) Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 39:450–456PubMedCrossRef

34.

Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17:968–975PubMed

35.

Idriss ZH, Sinno AA, Kronfol NM (1976) Tuberculous meningitis in childhood. Forty-three cases. Am J Dis Child 130:364–367

36.

Infuso A, Falzon D; on behalf of the EuroTB network (2006) European survey of BCG vaccination policies and surveillance in children. Euro Surveill 11:6–11PubMed

37.

Iseman MD (1993) Treatment of multidrug-resistant tuberculosis. N Engl J Med 329:784–791PubMedCrossRef

38.

Jacobsen M, Detjen A, Mueller H, Gutschmidt A, Leitner S, Wahn U, Magdorf K, Kaufmann SH (2007) Clonal expansion of CD8 + effector T cells in childhood tuberculosis. J Immunol 179:1331–1339PubMed

39.

Joint Tuberculosis Committee of the British Thoracis Society (1998) Chemotherapy and management of tuberculosis in the United Kingdom. Thorax 53:536–548CrossRef

40.

Kauschke K, Magdorf K, Wahn U (1998) Mykobakteriell bedingte Lymphadenitis bei Kindern in Berlin 1981–1996. Monatsschr Kinderheilk Suppl 2:S159

41.

Kumar R, Gupta N, Sabharwal AS (2005) Congenital tuberculosis. Indian J Pediatr 72:631–633PubMedCrossRef

42.

Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, Dockrell HM, Wilkinson RJ, Wood R (2007) Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 7:99PubMedCrossRef

43.

Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A (2004) Diagnosis of tuberculosis in South African children with a T-cell-bases assay: a prospective cohort study. Lancet 365:97–98

44.

Lobato MN, Hopewell PC (2000) Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 158:1871–1875

45.

Loddenkemper R (2005) Aktuelle Information des DZK zur Tuberkulinversorgung Deutschlands. Pneumologie 59:236–237PubMedCrossRef

46.

Maartens G, Wilkinson RJ (2007) Tuberculosis. Lancet 370:2030–2043PubMedCrossRef

47.

Magdorf K (2006) Tuberkulose im Kindesalter—Pathogenese, Prävention, Klinik und Therapie. Monatsschr Kinderheilk 154:124–132CrossRef

48.

Magdorf K (2003) Tuberkulose und nicht-tuberkulöse mykobakterielle Krankheiten. In: Handbuch, Infektionen bei Kindern und Jugendlichen, 4th edn. Futuramed, Munich, pp 699–719

49.

Magdorf K, Ertel M, Wahn U (1997) Tuberkulose im Kindesalter 2. Tuberkuloseformen, Symptomatik und Therapie. Pädiatr Prax 52:299–309

50.

Mandalakas AM, Starke JR (2005) Current concepts of childhood tuberculosis. Semin Pediatr Infect Dis 6:93–104CrossRef

51.

Marais BJ, Gie RP, Schaaf HS, Starke JR, Hesseling AC, Donald PR, Beyers N (2004) A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 34:886–894PubMedCrossRef

52.

Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N (2006) A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 118:1350–1359CrossRef

53.

Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N (2006) The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc lung Dis 10:732–738PubMed

54.

Martin C (2005) The dream of a vaccine against tuberculosis; New vaccines improving or replacing BCG? Eur Respir J 26:162–167PubMedCrossRef

55.

Matulis G, Jüni P, Villiger PM, Gadola SD (2007) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases performance of a mycobacteroim tuberculosis antigen specific IFN-gamma assay. Ann Rheum Dis 67:84–90PubMedCrossRef

56.

Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146:350–354

57.

Nakaoka H, Lawson L, Squire SB, Coulter B, Ravn P, Brock I, Hart CA, Cuevas LE (2006) Risk for tuberculosis among children. Emerg Infect Dis 12:1383–1388PubMed

58.

National Institute for Health and Clinical Excellence. (2006) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. http://www.nice.org.uk. Accessed 10 April 2008

59.

Neutra MR, Mantis NJ, Kraehenbuhl JP (2001) Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2:1004–1009PubMedCrossRef

60.

O’Brien RJ, Spigelman M (2005) New drugs for tuberculosis: current status and future prospects. Clin Chest Med 26:327–340PubMedCrossRef

61.

Ormerod P (2001) Tuberculosis in pregnancy and the puerperium. Thorax 56:494–499PubMedCrossRef

62.

Ozuah PO, Ozuah TP, Stein REK, Burton W, Mulvihill M (2001) Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children. JAMA 285:451–453PubMedCrossRef

63.

Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6:413–422PubMedCrossRef

64.

Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, Kalantri S (2007) Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 35:98–103PubMedCrossRef

65.

Piana F, Ruffo Codecasa L, Baldan R, Miotto P, Ferrarese M, Cirillio DM (2007) Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations. New Microbiol 30:286–290PubMed

66.

Ridzon R, Meador J, Maxwell R, Higgins K, Weismuller P, Onorato IM (1997) Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin. Clin Infect Dis 24:1264–1265PubMed

67.

Robert Koch-Institut (2005) Infektionsepidemiologisches Jahrbuch für 2004. Robert Koch-Institut, Berlin, pp 162–165

68.

Romanus V, Hallander H, Wahlen P, Olinder-Nielsen A, Magnusson P, Juhlin I (1995) Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination. Tuber Lung Dis 76:300–310PubMedCrossRef

69.

Sacchettini JC, Rubin EJ, Freundlich JS (2008) Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol 6:41–52PubMedCrossRef

70.

Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR (1997) Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 99:226–231PubMedCrossRef

71.

Sharma SK, Mohan A, Sharma A, Mitra DK (2005) Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5:415–430PubMedCrossRef

72.

Skevaki CL, Kafetzis DA (2005) Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues. Paediatr Drugs 7:219–234PubMedCrossRef

73.

Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, Gourgiotis D, Tsolia MN (2007) The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 45:715–722PubMedCrossRef

74.

Starke JR (2006) Interferon-gamma release assays for diagnosis of tuberculosis infection in children. Pediatr Infect Dis J 25:941–942PubMedCrossRef

75.

Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M (2007) Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 4:e202PubMedCrossRef

76.

Swaminathan S, Raghavan A, Duraipandian M, Kripasankar AS, Ramachandran P (2005) Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. Int J Tuberc Lung Dis 9:693–696PubMed

77.

Thee S, Detjen A, Quarcoo D, Wahn U, Magdorf K (2007) Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children. Int J Tuberc Lung Dis 11:965–971PubMed

78.

Thuong NT, Hawn TR, Thwaites GE, Chau TT, Lan NT, Quy HT, Hieu NT, Aderem A, Hien TT, Farrar JJ, Dunstan SJ (2007) A polimorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 8:422–428PubMedCrossRef

79.

Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, White NJ, Tran TH, Summers D, Farrar JJ (2007) Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 6:230–236PubMedCrossRef

80.

Tsiouris SJ, Austin J, Toro P, Coetzee D, Weyer K, Stein Z, El-Sadr WM (2006) Results of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis 10:939–941PubMed

81.

Ulrichs T, Kaufmann SHE (2003) Immunology and persistence. Issues Infect Dis 2:112–127CrossRef

82.

Verver S, van Loenhout-Rooyackers JH, Bwire R, Annee-van Bavel JA, de Lange HJ, van Gerven PJ, Borgdorff MW (2005) Tuberculosis infection in children who are contacts of immigrant tuberculosis patients. Eur Respir J 26:126–132PubMedCrossRef

83.

World Health Organisation (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO/HTM/ TB/2006.371. WHO, Geneva

84.

World Health Organisation (2006) Ethambutol efficacy and toxicity. Literature review and recommendations for daily and intermittent dosage in children. WHO/HTM/TB/2006.365; WHO/FCH/CAH/2006.3. WHO, Geneva

85.

Wiese-Posselt M, Siedler A, Rademacher A, Haas W (2004) ESPID-study-group 2 incidence of nontuberculous mycobacteria (NTM) in children aged <15 years, Germany 2002–2004. ESPID annual meeting, Tampere, Finland, May 2004

86.

Zar HJ, Hanslo D, Apolles P (2005) Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 365:130–134PubMedCrossRef

Titel: Proposed management of childhood tuberculosis in low-incidence countries
verfasst von: Klaus Magdorf
Anne K. Detjen
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: European Journal of Pediatrics / Ausgabe 8/2008
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-008-0730-1

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Proposed management of childhood tuberculosis in low-incidence countries

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2008

Fasting adaptation in idiopathic ketotic hypoglycemia: a mismatch between glucose production and demand

Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP

Prospective evaluation of the pharmacodynamics of piritramide in neonates and infants

Blue rubber bleb nevus syndrome with simultaneous neurological and skeletal involvement

Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin

Cold medication containing oral phenylephrine as a cause of hypertension in children

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie